BioXcel Therapeutics Inc (BTAI)
2.24
-0.04
(-1.75%)
USD |
NASDAQ |
Mar 18, 11:36
BioXcel Therapeutics Enterprise Value: 71.79M for March 17, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Omeros Corp | 560.03M |
| Chimerix Inc | 625.53M |
| scPharmaceuticals Inc | 109.74M |
| IGM Biosciences Inc | -110.26M |
| ZyVersa Therapeutics Inc | 1.729M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.65M |
| Revenue (Quarterly) | 0.214M |
| Total Expenses (Quarterly) | 13.95M |
| EPS Diluted (Quarterly) | -5.12 |
| Gross Profit Margin (Quarterly) | -446.7% |
| Profit Margin (Quarterly) | -6.38K% |
| Earnings Yield | -1.54K% |
| Normalized Earnings Yield | -1501.50 |